Immune globulins are effective in severe pediatric Guillain-Barre syndrome

Pediatric Neurology

Volumn 16, Issue 1, 1997, Pages 32-36

  Shahar, Eli ^a   Shorer, Zamir ^b   Roifman, Chaim M ^d   Levi, Yaacov ^b   Brand, Natan ^c   Ravid, Sarit ^a   Murphy, E Gordon ^d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISABILITY; DRUG EFFICACY; DRUG MEGADOSE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE;

EID: 0031041324     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(96)00253-6     Document Type: Article

References (36)

1. [1] Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3:565-7.
2. [2] Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
3. [3] Evans OB. Guillain-Barré syndrome in children. Pediatr Rev 1986;8:69-74.
4. [4] Briscoe DM, McMenamin JB, O'Donohoe NV. Prognosis in Guillain-Barré syndrome. Arch Dis Child 7987;62:733-5.
5. [5] McKhann GM. Guillain-Barré syndrome. Clinical and therapeutic observations. Ann Neurol 1990;27(suppl):S13-6.
6. [6] Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain-Barré syndrome. Ann Neurol 1990;28:65-9.
7. [7] Lamont PJ, Johnston HM, Berdoukas VA. Plasmapheresis in children with Guillain-Barré syndrome. Ann Neurol 1991;41:1928-31.
8. [8] McFarlin DE. Immunological parameters in Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S25-9.
9. [9] Koski CL, Gratz E, Sutherland J, Mayer RF. Clinical correlation with anti-peripheral nerve myelin antibodies in Guillain-Barré syndrome. Ann Neurol 1986;19:573-7.
10. [10] Koski CL. Characterization of complement-fixing antibodies to peripheral myelin in Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S44-7.
11. [11] Rodnitzki RL, Goeken JA. Complications of plasma exchange in neurological patients. Arch Neurol 1982;39:1090-1.
12. [12] Reimann PM, Mason PD. Plasmapheresis: Technique and complications. Intensive Care Med 1990;16:3-10.
13. [13] Cosi V, Lombardi M, Picollo G, Erbetta A. Treatment of myasthenia gravis with high-dose intravenous immunoglobulins. Acta Neurol Scand 1991;84:81-4.
14. [14] Roifman CM, Scahffer FM, Wachsmuth SE, Murphy G, Gelfand EW. Reversal of chronic polymyositis following intravenous serum globulin therapy. JAMA 1987;258:513-5.
15. [15] Cornblath DR, Chaudhry V, Griffin JW. Treatment of chronic demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 1991;30:104-6.
16. [16] Vedanarayanan VV, Kandt RS, Lewis DV, DeLong JR. Chronic inflammatory polyradiculopathy of childhood. Treatment with high-dose intravenous immunoglobulin. Neurology 1991;41:828-30.
17. [17] Nisonoff A. Idiotypes. Concepts and applications. J Immunol 1991;147:2429-38.
18. [18] Thorton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35:260-8.
19. [19] Kleyweg RP, van der Meche PGA, Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulins. Neurology 1988;38:1639-41.
20. [20] Shahar E, Gordon EG, Roifman CM. Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome. J Pediatr 1990;116:141-4.
21. [21] Shahar E, Brand N. High-dose intravenous immunoglobulins treatment of severe pediatric Guillain-Barré syndrome (in Hebrew). Harefuha 1991;121:225-8.
22. [22] Urtusun M, Lopez-de-Munain A, Carrera N, et al. High dose intravenous immune globulin in the management of severe Guillain-Barré syndrome. Ann Pharmacother 1992;26:32-3.
23. [23] Ragah A. The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome. Anaesthesia 1992;47:220-2.
24. [24] Heaton PAJ. Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin. NZ Med J 1992;105:477-8.
25. [25] Jackson MC, Godwin-Austen RB, Whiteley AM. High-dose intravenous immunoglobulin in the treatment of Guillain-Barré syndrome: A preliminary open study. J Neurol 1993;240:51-3.
26. [26] Notarangelo LD, Duse M, Tiberti S, et al. Intravenous immunoglobulin in two children with Guillain-Barré syndrome. Eur J Pediatr 1993;152:372-4.
27. [27] Valle L, Dulac O, Nuyts JP, Leclerc F, Vamecq J. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children. Neuropediatrics 1993;24:235-6.
28. [28] Al-Qudah AA. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood. J Child Neurol 1994;9:178-80.
29. [29] van der Meche FGA, Schmitz PIZ, and the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in globulin syndrome. N Engl J Med 1992;326:1123-9.
30. [30] Irani DN, Cornblath DR, Chaundhry V, Borel C, Haneley DF. Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology 1993;43:872-5.
31. [31] Castro LHM, Ropper AH. Human Immune globulin infusion in Guillain-Barré syndrome: Worsening during and after treatment. Neurology 1993;43:1034-6.
32. [32] Gurses N, Uysal S, Cetinkaya F, Islek I, Kalayci AG. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Scand J Infect Dis 1995;27:241-3.
33. [33] Reisin RC, Pocienca J, Rodriguez E, et al. Severe Guillain-Barré syndrome in childhood treated with human immune globulin. Pediatr Neurol 1996;14:308-12.
34. [34] Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndrome. Neurology 1996;46:100-3.
35. [35] Peck TP, IVIg for GBS: Potential problems in the alpha soup. Neurology 1993;43:857-8.
36. [36] The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: A pilot study. Ann Neurol 1994;35:749-52.